Trough 1 | Trough 2 | Trough 3 | ANOVA P | Average CV (%) | Peak 1 | Peak 2 | Peak 3 | ANOVA P | Average CV (%) | |
---|---|---|---|---|---|---|---|---|---|---|
Rivaroxaban 20 | ||||||||||
N Median Min-max | 29 1.34 1.08–3.36 | 30 1.32 0.94–1.81 | 30 1.34 1.01–1.67 | 0.029* | 30 4.8 0.72–40.7 | 29 3.77 1.96–6.2 | 30 3.71 2.10–5.88 | 30 3.69 1.89–5.49 | 0.297 | 30 9.4 1.89–24.9 |
Rivaroxaban 15 | ||||||||||
N Median Min-max | 30 1.32 1.02–2.53 | 30 1.30 1.03–2.78 | 29 1.37 0.93–3.23 | 0.914 | 30 4.61 1.61–24.7 | 30 3.53 2.08–6.58 | 30 3.27 1.89–6.17 | 28 3.14 1.80–7.03 | 0.303 | 30 8.34 0.56–28.1 |